Idiopathic Pulmonary Fibrosis

November 24, 2015November 24, 2015

Pulmonary Fibrosis Foundation Reaches Out to Caregivers

The Pulmonary Fibrosis Foundation (PFF) has announced that it has acquired the Daughters of Pulmonary Fibrosis program to better serve the pulmonary fibrosis (PF) community, with all funds raised going to ... Read more

November 19, 2015May 12, 2016

Third Biennial PFF Summit 2015: From Bench to Bedside

Idiopathic Pulmonary Fibrosis, News

The 14th of November 2015 marked the Third Biennial Pulmonary Fibrosis Foundation (PFF) Summit 2015: From Bench to Bedside, which was held in Washington D.C. According to a press release, more than 700 researchers, ... Read more

November 17, 2015November 18, 2015

Pulmonary Fibrosis Lung Repair Using Stem Cells Could Depend on Age of Donor

Idiopathic Pulmonary Fibrosis, News

A team of researchers from the Miller School of Medicine recently discovered that the age of a donor mouse impacts the ability of its mesenchymal stem cells (MSCs) to repair lung damage caused ... Read more

November 16, 2015May 12, 2016

Boehringer Ingelheim’s IPF Therapy OFEV Shows Further Safety, Efficacy

Idiopathic Pulmonary Fibrosis

Boehringer Ingelheim presented new analyses showing OFEV® continued to be safe and tolerable for the treatment of idiopathic pulmonary fibrosis (IPF) in clinical use and in an extension study. The analyses ... Read more

November 13, 2015November 13, 2015

PFF Survey Finds Diagnostic Delays, Misdiagnosis Plague ILD Patients

Idiopathic Pulmonary Fibrosis, News

Results from national survey of 600 U.S. patients with interstitial lung disease (ILD) indicate that a substantial percentage suffer from diagnostic delays and misdiagnosis. The data was presented at the PFF Summit ... Read more

November 12, 2015November 12, 2015

Novel Severe Lung Disease Drug Therapy Pushing Forward

Idiopathic Pulmonary Fibrosis, News

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and clinical development of innovative Physiocrine-based medicines for patients suffering from severe rare diseases, recently announced that it has designated ... Read more

November 10, 2015

PFF Summit 2015 Presentations To Include Promising Early-stage Research And Patient Outcomes Data

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF), a pulmonary fibrosis (PF) information resource, has announced a record number of scientific poster presentations concerning idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases to ... Read more

November 9, 2015November 9, 2015

PFF and Boehringer Partner to Promote Research, Care

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) recently announced a five-year partnership with the research-driven pharmaceutical company Boehringer Ingelheim. Through the collaboration, the two aim to raise awareness of pulmonary fibrosis in the community, offer educational ... Read more

October 29, 2015November 5, 2015

Boehringer Reports Efficacy of OFEV in Idiopathic Pulmonary Fibrosis Studies

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals, Inc., recently presented post-hoc analyses from the Phase III INPULSIS™ clinical trials at the American College of Chest Physicians Annual Meeting (CHEST 2015) in Montreal, Canada. Results ... Read more

October 29, 2015November 5, 2015

Disease-Relevant In Vitro and In Vivo Models for Lung Fibrosis Focus of Webinar

Idiopathic Pulmonary Fibrosis, News

On Nov. 12, 2015, experts from Charles River will host a live broadcast presentation through Xtalks entitled “Disease Relevant In Vitro and In Vivo Models for Lung Fibrosis” in which they will provide a series of ... Read more